Clinicopathologic characteristics and survival of patients with primary effusion lymphoma

References

• Said CE. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Reasearch on Cancer (IARC); 2017. p. 323–324.
   Google Scholar
• Cesarman E, Chang Y, Moore PS, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332(18):1186–1191.
   PubMed Web of Science ®Google Scholar
• Knowles DM, Inghirami G, Ubriaco A, et al. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood. 1989;73(3):792–799.
   PubMed Web of Science ®Google Scholar
• Sen S, Marley E, Naina HV. Prognostic factors and outcomes in primary effusion lymphoma in HIV-infected patients: a single center experience. Blood. 2014;124(21):5415–5415.
   Web of Science ®Google Scholar
• Boulanger E, Afonso PV, Yahiaoui Y, et al. Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin. Am J Transplant. 2008;8(3):707–710.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Shum H, Lahijani M, et al. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved. Leuk Lymphoma. 2012;53(12):2378–2382.
   PubMed Web of Science ®Google Scholar
• Gupta A, Sen S, Marley E, et al. Management and outcomes of HIV-associated primary effusion lymphoma: a single center experience. Clin Lymphoma, Myeloma Leuk. 2016;16:S175–S80.
   PubMed Web of Science ®Google Scholar
• Klepfish A, Zuckermann B, Schattner A. Primary effusion lymphoma in the absence of HIV infection - clinical presentation and management. QJM. 2015;108(6):481–488.
   PubMed Web of Science ®Google Scholar
• Kumode T, Ohyama Y, Kawauchi M, et al. Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma. Leuk Lymphoma. 2013;54(9):1947–1952.
   PubMed Web of Science ®Google Scholar
• Shin J, On behalf of the Consortium for Improving Survival of Lymphoma investigators, Ko YH, Oh SY, et al. Body cavity-based lymphoma in a country with low human immunodeficiency virus prevalence: a series of 17 cases from the consortium for improving survival of lymphoma. Cancer Res Treat. 2019;51(4):1302–1312.
   PubMed Web of Science ®Google Scholar
• Dinmohamed AG, Visser O, Doorduijn JK, et al. Treatment and survival of patients with primary effusion lymphoma in the Netherlands. HemaSphere. 2018;2(5):e143.
   PubMed Web of Science ®Google Scholar
• Qunaj L, Castillo JJ, Olszewski AJ. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Leuk Lymphoma. 2017;8194:1–9.
   Google Scholar
• Simonelli C, Spina M, Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. JCO. 2003;21(21):3948–3954.
   PubMed Web of Science ®Google Scholar
• Boulanger E, Gérard L, Gabarre J, et al. Prognostic factors and outcome of human herpesvirus 8 – associated primary effusion lymphoma in patients with AIDS. JCO. 2005;23(19):4372–4380.
   PubMed Web of Science ®Google Scholar
• Guillet S, Gérard L, Meignin V, et al. Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution. Am J Hematol. 2016;91(2):233–237.
   PubMed Web of Science ®Google Scholar
• Lurain K, Polizzotto MN, Aleman K, et al. Viral, immunologic, and clinical features of primary effusion lymphoma. Blood. 2019;133(16):1753–1761.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kamitsuji Y, Kuroda J, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: Report of 2 cases and review of 212 cases in the literature. Acta Haematol. 2007;117(3):132–144.
   PubMed Web of Science ®Google Scholar
• Huang Q, Chang KL, Gaal K, et al. Primary effusion lymphoma with subsequent development of a small bowel mass in an HIV-seropositive patient: a case report and literature review. Am J Surg Pathol. 2002;26(10):1363–1367.
   PubMed Web of Science ®Google Scholar
• Shah NN, Singavi AK, Harrington A. Daratumumab in primary effusion lymphoma. N Engl J Med. 2018;379(7):689–690.
   PubMed Web of Science ®Google Scholar
• Kabiawu-Ajise OE, Harris J, Ismaili N, et al. Primary effusion lymphoma with central nervous system involvement in an HIV-negative homosexual male. Acta Haematol. 2012;128(2):77–82.
   PubMed Web of Science ®Google Scholar
• Narkhede M, Arora S, Ujjani C. Primary effusion lymphoma: current perspectives. OTT. 2018;Volume 11:3747–3754.
   Web of Science ®Google Scholar
• Brimo F, Michel RP, Khetani K, et al. Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer. 2007;111(4):224–233.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Farre B, Martinez D, Lopez-Guerra M, et al. HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma. Mod Pathol. 2017;30(5):745–760.
   PubMed Web of Science ®Google Scholar
• Ammari ZA, Mollberg NM, Abdelhady K, et al. Diagnosis and management of primary effusion lymphoma in the immunocompetent and immunocompromised hosts. Thorac Cardiovasc Surg. 2013;61(04):343–349.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Trivedi P, Horncastle D, et al. CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease. Histopathology. 2009; 55(3):358–359.
   PubMed Web of Science ®Google Scholar
• Pérez CL, Rudoy S. Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient. Clin Diagn Lab Immunol. 2001;8(5):993–996.
   PubMedGoogle Scholar
• Lim ST, Rubin N, Said J, et al. Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab. Ann Hematol. 2005;84(8):551–552.
   PubMed Web of Science ®Google Scholar